Figure 1.
Diagnoses of primary immunodeficiency patients who were treated with virus-specific T-cell therapy. ALPS, autoimmune lymphoproliferative syndrome; CGD, chronic granulomatous disease; CID, combined immunodeficiency; HLH, hemophagocytic lymphohistiocytosis; HIGM, hyper-immunoglobulin M syndrome; LAD1, leukocyte adhesion deficiency type I; MHC II, major histocompatibility complex deficiency type II; NK, natural killer; SCAEBV, severe chronic active EBV; WAS, Wiskott-Aldrich syndrome; XLP, X-linked lymphoproliferative disorder.

Diagnoses of primary immunodeficiency patients who were treated with virus-specific T-cell therapy. ALPS, autoimmune lymphoproliferative syndrome; CGD, chronic granulomatous disease; CID, combined immunodeficiency; HLH, hemophagocytic lymphohistiocytosis; HIGM, hyper-immunoglobulin M syndrome; LAD1, leukocyte adhesion deficiency type I; MHC II, major histocompatibility complex deficiency type II; NK, natural killer; SCAEBV, severe chronic active EBV; WAS, Wiskott-Aldrich syndrome; XLP, X-linked lymphoproliferative disorder.

Close Modal

or Create an Account

Close Modal
Close Modal